Developed for chronic gout to manage uric acid levels and support long-term relief from joint pain.
Mechanism of Action
Febuxostat is a potent, non-purine selective inhibitor of xanthine oxidase. It prevents the formation of uric acid from hypoxanthine and xanthine, effectively lowering serum urate levels and preventing the deposition of urate crystals in joints.
Route of Administration
Oral
Onset Time
2–4 days
Duration
24 hours
Contraindications
Concurrent use of azathioprine, Concurrent use of mercaptopurine, Hypersensitivity to febuxostat
Severe Adverse Events
Cardiovascular death risk, Myocardial infarction, Liver failure — requires immediate medical attention
Information related to Uloric is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
